Xyzal gets competition from Dr Reddy's US generic rival
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
Dr Reddy’s has launched a generic competitor to Sanofi Consumer Healthcare’s levocetirizine-based Xyzal Allergy 24HR in the US.